Join BJS Academy
BJS Academy>Randomized clinical ...>Preoperative treatme...
Normal View Dyslexic View

Preoperative treatment of locally advanced rectal cancer

18 October 2023
Randomized clinical trials Colorectal
Schrag D, Shi Q, Weiser MR, Gollub MJ, Saltz LB, Musher BL et al.

N Engl J Med 2023; 389: 322-334.

Some 1194 patients with stage T2 or T3 rectal cancer were randomized to neoadjuvant chemoradiotherapy (standard care) or chemotherapy alone. Five-year disease-free survival was 80.8 per cent after chemotherapy alone compared to 78.6 per cent after standard care, P=0.005 for noninferiority. Overall survival rates were similar.

Comment: This is important as it could change standard care. Surgeons have never been keen to operate on recently irradiated tissue.

BJS Foundation Limited
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
rct078
Randomized clinical trials
Randomized clinical trials
Colorectal
Preoperative treatment of locally advanced rectal cancer
Schrag D, Shi Q, Weiser MR, Gollub MJ, Saltz LB, Musher BL et al.
18102023
N Engl J Med 2023; 389: 322-334.
Some 1194 patients with stage T2 or T3 rectal cancer were randomized to neoadjuvant chemoradiotherapy (standard care) or chemotherapy alone. Five-year disease-free survival was 80.8 per cent after chemotherapy alone compared to 78.6 per cent after standard care, P=0.005 for noninferiority. Overall survival rates were similar.
Comment: This is important as it could change standard care. Surgeons have never been keen to operate on recently irradiated tissue.
Published on: 18 October 2023
Article ID: rct078

Related articles

Morbidity after mechanical bowel preparation and oral antibiotics prior to rectal resection. The MOBILE2 randomized clinical trial.

Koskenvuo L, Lunkka P, Varpe P, Hyoty M, Satokari R, Haapamaki C et al.

25 September 2024

Pyridostigmine to reduce the duration of postoperative Ileus after colorectal surgery (PyRICo-RCT): randomized clinical trial.

Traeger L, Bedrikovetski S, Fitzsimmons T, Nguyen T-M, Moore JW, Lewis M et al.

7 August 2024

Sacral neuromodulation versus conservative treatment for refractory idiopathic slow-transit constipation. The randomized clinical No.2-Trial.

Heemskerk SC, Dirksen CD, van Kuijk SMJ, Benninga MA, Baeten C, Masclee AAM et al.

30 August 2024
Home
  • Normal view
  • Dyslexic view
Info
Copied!